Stock NBIX NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Delayed Nasdaq
Other stock markets
 03:51:49 2024-04-25 pm EDT 		5-day change 1st Jan Change
137 USD -1.39% Intraday chart for Neurocrine Biosciences, Inc. +3.45% +4.06%
Apr. 24 Wells Fargo Upgrades Neurocrine Biosciences to Overweight From Equalweight, Price Target is $170 MT
Apr. 24 Neurocrine Biosciences, Inc. Launches What the C@H! Educational Initiative to Support Congenital Adrenal Hyperplasia Community CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. Revisions Neurocrine Biosciences, Inc.